To Assess Adherence to the Treatment and Quality of Life in Patients With Hypertension

Hypertension and Health-Related Quality of Life Adherence: Cross- Sectional Observational Study in Ambulatory Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00944489

Acronym

ADHERENCE

Enrollment

1150

Registered

2009-07-23

Start date

2009-08-31

Completion date

2010-01-31

Last updated

2010-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

Hypertension, Health-Related Quality of Life Adherence to the antihypertension treatment, Ambulatory Patients, MINICHAL score, Treatment Adherence Scale (MMAS), Quality of life, Adherence to treatment

Brief summary

The main goal of this study is to achieve a deeper knowledge of the adherence to antihypertensive drug treatment and to evaluate the quality of life in this population. This work has the following goals: primary objective is to assess the antihypertensive treatment adherence in patients with essential hypertension on treatment for more than 6 months. The secondary objectives include the assessment of quality of life, identification of associated factors that affect adherence, knowledge of drugs used and comparison of levels of adherence according to the different drug regimes Two questionnaires shall be prepared The first questionnaire shall be anonymously completed by the patient willing to participate. It is divided into two parts: 1. Treatment Adherence Scale (MMAS): this survey is made up of 4 questions having YES/No answers and it grants 1 point per every NO answer, and zero points to every YES answer. 2. The second part is the health-related quality of life Questionnaire (MINICHAL). The questions refer to the last 7 days with 4 possible answer options: 0 (no, absolutely not), 1 (yes, sometimes), 2 (yes, frequently) and 3 (yes, a lot). It is made up of 16 items, 10 correspond to the State of Mind dimension and 6 to the Body-related Symptoms, also described as Physical symptoms. The second questionnaire shall be completed by the intervening physician as regards patients that attend medical visits, and who have answered the anonymous questionnaire.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

21 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients with diagnosis of essential hypertension under the criteria established by the Joint National Committee VII (9) and those patients under pharmacological treatment with the same therapeutic regime during at le

Exclusion criteria

* Patients with secondary HBP * Pregnant women or nursing mothers * Patients with acute illnesses or having a definite psychiatric diagnosis, as well as those patients who are unable to completed

Design outcomes

Primary

Measure	Time frame
First questionnaires for patient:Treatment Adherence Scale, and the health-related quality of life Questionnaire .the intervening physician completed second questionnaire with all about the non and pharmacology treatment	3-6 months

Secondary

Measure	Time frame
Assess quality of life in patients in this cohort.	3-6 months
Identify associated factors that may alter adherence to antihypertensive treatment.	3-6 months
Know pharmacological groups used for this pathology and compare treatment adherence level according to the different therapeutic regimes used	3-6 months

Countries

Argentina

Outcome results